Methods and Apparatus for Nanoparticle-assisted Nucleic Acid Amplification, Hybridization and Microarray Analysis
20170275680 · 2017-09-28
Inventors
Cpc classification
C12Q2537/143
CHEMISTRY; METALLURGY
B82Y15/00
PERFORMING OPERATIONS; TRANSPORTING
C12Q1/6806
CHEMISTRY; METALLURGY
C12Q2537/143
CHEMISTRY; METALLURGY
International classification
Abstract
Nucleic acid hybridization methods are disclosed. An example method comprises: immobilizing probe nucleic acid molecules on a surface; flowing target nucleic acid molecules to the immobilized probe nucleic acid molecules on said surface in a hybridization buffer solution; washing said surface with a wash solution which comprises nanoparticles; and detecting the presence of duplexes on said surface comprising a strand of one of said target nucleic acid molecules and a strand of one of said probe nucleic acid molecules. In some embodiments, the target nucleic acid molecules are generated using a helicase-dependent amplification method wherein the reaction solution comprises nanoparticles.
Claims
1. A nucleic acid hybridization method, comprising: a) immobilizing probe nucleic acid molecules on a surface; b) flowing target nucleic acid molecules to the immobilized probe nucleic acid molecules on said surface in a hybridization buffer solution; c) washing said surface with a wash solution which comprises nanoparticles; and d) detecting the presence of duplexes on said surface comprising a strand of one of said target nucleic acid molecules and a strand of one of said probe nucleic acid molecules.
2. The method according to claim 1, wherein prior to the hybridization method the target nucleic acid molecules are generated using an isothermal nucleic acid amplification method, the amplification method comprising: (i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles, (ii) allowing the substrate nucleic acid molecules to be denatured by the helicase, (iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules, (iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to generate duplex molecules, and (v) repeating steps (i) through (iv) for a plurality of cycles to amplify the substrate nucleic acid molecules, wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products, and wherein the concentration and other parameters of the nanoparticles in the amplification method and the washing step of the hybridization method are independently optimized.
3. The method according to claim 1, wherein the nanoparticles are generally spherical in shape.
4. The method according to claim 3, wherein the nanoparticles are sized between 1 and 10 nanometers.
5. The method according to claim 4, wherein the nanoparticles have an average diameter of about 5 nanometers.
6. The method according to claim 1, wherein the nanoparticles are coated with negative charged ions.
7. The method according to claim 6, wherein the nanoparticles are coated with citrate.
8. The method according to claim 1, wherein surfaces of the nanoparticles are loaded with oligonucleotide stabilizers whose sequences are irrelevant with respect to the sequences of the probe nucleic acid molecules or the target nucleic acid molecules.
9. The method according to claim 8, wherein the length of the oligonucleotide stabilizers is 20-mer or shorter.
10. The method according to claim 9, wherein the length of the oligonucleotide stabilizers is 15-mer or shorter.
11. The method according to claim 10, wherein the length of the oligonucleotide stabilizers is 12-mer.
12. The method according to claim 1, wherein the concentration of the nanoparticles in the wash solution is in a range of 2 to 20 nM.
13. The method according to claim 1, wherein the concentration of NaCl in the wash solution is in a range of 50 to 300 nM.
14. The method according to claim 1, wherein the nanoparticles comprise gold nanoparticles.
15. The method according to claim 1, wherein the washing step is performed at an ambient temperature.
16. The method according to claim 1, wherein the washing step is performed at a temperature below 30° C.
17. The method according to claim 16, wherein the washing step is performed at a temperature between 20° C. and 25° C.
18. A microarray method comprising: a) providing a solid support; b) immobilizing a plurality of nucleic acid probes at discrete positions on the support; c) exposing a sample solution to the probes, the sample solution comprising sample nucleic acid molecules; d) washing off the sample solution with a wash solution which comprises nanoparticles; and e) determining the degree of hybridization between the sample molecules and the probes.
19. The method according to claim 18, wherein prior to the microarray method the sample nucleic acid molecules are generated using an isothermal nucleic acid amplification method, the amplification method comprising: (i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles, (ii) allowing the substrate nucleic acid molecules to be denatured by the helicase, (iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules, (iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to generate duplex molecules, and (v) repeating steps (i) through (iv) for a plurality of cycles to amplify the substrate nucleic acid molecules, wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products, and wherein the concentration and other parameters of the nanoparticles in the amplification method and the washing step in the microarray method are independently optimized.
20. A method of using a microfluidic microarray assembly (MMA) comprising: (a) providing a test chip; (b) providing a first channel plate sealingly connectable to said test chip for applying at least one probe reagent to said test chip, wherein said first channel plate comprises a plurality of first microfluidic channels configured in a first predetermined reagent pattern; (c) assembling said first channel plate to said test chip; (d) flowing said at least one probe reagent through said first microfluidic channels to form a first array of said at least one probe reagent on said test chip in said first predetermined reagent pattern; (e) immobilizing said at least one probe reagent on said test chip; (f) removing said first channel plate from said test chip; (g) providing a second channel plate sealingly connectable to said test chip for applying at least one sample reagent to said test chip, wherein said second channel plate comprises a plurality of second microfluidic channels configured in a second predetermined pattern differing from said first predetermined pattern; (h) assembling said second channel plate to said test chip; (i) flowing said at least one sample reagent through said second microfluidic channels to form a second array, wherein said second array intersects said first array at said test locations; (j) flowing a wash solution which comprises nanoparticles through said second microfluidic channels; and (k) detecting any hybridization products at said test locations.
21. The method according to claim 20, wherein said at least one probe reagent comprises a plurality of different probes, wherein each of said probes is flowable through separate ones of said first microfluidic channels.
22. The method according to claim 21, wherein said at least one sample reagent comprises a plurality of different test samples, wherein each of said samples is flowable through separate ones of said second microfluidic channels.
23. The method according to claim 20, wherein one of said first and second predetermined reagent patterns is a radial pattern and the other of said first and second predetermined reagent patterns is a spiral pattern.
24. The method according to claim 20, wherein said at least one sample reagent comprises nucleic acid molecules which are generated using an isothermal nucleic acid amplification method prior to the MMA method, the amplification method comprising: (i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles, (ii) allowing the substrate nucleic acid molecules to be denatured by the helicase, (iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules, (iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to generate duplex molecules, and (v) repeating steps (i) through (iv) for a plurality of cycles to amplify the substrate nucleic acid molecules, wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products, and wherein the concentration and other parameters of the nanoparticles in the amplification method and the washing step in the MMA method are independently optimized.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0037] In drawings which show non-limiting embodiments of the invention:
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
DETAILED DESCRIPTION
[0051] Throughout the following description, specific details are set forth in order to provide a more thorough understanding of the invention. However, the invention may be practiced without these particulars. In other instances, well-known elements have not been shown or described in detail to avoid unnecessarily obscuring the invention. Accordingly, the specification and drawings are to be regarded in an illustrative, rather than a restrictive, sense.
[0052] A microfluidic bioarray technique has been developed, and this technique uses gold nanoparticles (AuNP targets) for specific detection of single nucleotide polymorphism (SNP). In this technique, no temperature stringency is required, and high specificities in hybridization are achieved by loading the target strands on the crusts of small gold nanoparticles (AuNPs) prior to their hybridization to the oligonucleotide probes immobilized on the microfluidic channel surfaces. Our kinetic studies of DNA hybridization using surface plasmon resonance (SPR) spectroscopy has showed that AuNPs enhanced the dehybridization of the mismatch (MM) duplexes more than that of perfectly matched (PM) duplexes, thus accounting for most of the SNP discrimination power of the AuNP-enabled technique. However, the AuNP targets result in lower hybridization signal intensities than the free target counterparts (See
[0053] As inspired from our kinetic analysis, we know that the influence of AuNPs is predominantly on dehybridization. Therefore, we attempt to develop a method to use AuNPs in the washing (dehybridization) step, rather than using them in the hybridization step. In this method, a buffer solution containing AuNPs (5-nm diameter or some other suitable size) is used to flow over the surface-bound duplexes for the removal of the hybridized oligonucleotides by washing (
[0054] For nucleic acid analysis, we have previously developed a CD-like chip for microfluidic DNA hybridization that provides the advantage of fast analyses and multiplex capability. This platform, termed as CD-like NanoBioArray chip or CD-NBA chip, utilizes the centrifugal force in order to flow in the target solutions within the microfluidic channels. As shown in
where S.sub.pm and S.sub.mm are signal intensities at the PM and MM patches, respectively. In DNA microarrays, the nonspecific signals are inevitably detected and they are conventionally reduced by conducting a stringent wash subsequent to DNA hybridization. To compare the methods of AuNP wash and stringent wash, we flow the hybridization buffer (SSC 1×) in the spiral channels at room temperature, with or without AuNPs, respectively. The stringent wash only results in a specificity of 1.3 (compared to 1 in “no wash” channels). On the other hand, the use of AuNPs in the wash step helped to improve specificity to 2.6 but it was only in the presence of AuNPs of 5 nm, but not of 10, 12 and 20 nm, in diameter that the specificity was enhanced by washing (˜2.6). This result is in agreement with the previous observation, in which AuNPs have been used in the hybridization step.
Signal/Specificity Correlation in AuNP Wash Technique
[0055] In the stringent wash method, high-temperature or/and low-salt conditions are used to create a destabilizing environment for the formed duplexes and accelerate their dehybridization. This method aims to remove the nonspecific duplexes more than their specific counterparts, thus enhancing the specificity. We compare the AuNP wash and the stringent wash methods directly.
where S.sub.pm is the PM signal intensities at different washing condition; is the specificity (calculated by Eq. 1) at each washing condition;
[0056] While r=0 shows no correlation or the situation when specificity is achieved without a loss in signal, r=−1 shows the highest anticorrelation between the signal and specificity. From the signals and specificities shown in
[0057] The difference between the r values obtained from AuNP wash and stringent wash is also illustrated in our analysis of ˜400 hybridization patches obtained by both methods.
[0058] The outcome of high σ and minimal loss in SNR observed with the AuNP wash method can be explained in terms of the dehybridization rate constant k.sub.d, which is experimentally determined from our kinetic analyses using SPR spectroscopy. As shown in Table 1, for the MM duplex the k.sub.d value (in 10.sup.−4 s.sup.−1) is observed to enhance by five times, i.e. from 3.2 for stringent wash to 15.9 for AuNP wash at 22° C. On the other hand, the k.sub.d value (in 10.sup.−4 s.sup.−1) for the PM duplex has not increased much, i.e. from 1.7 for stringent wash to 3.0 for AuNP wash. This increase in the k.sub.d value for AuNP wash (less than two-fold) is much smaller than the corresponding increase for 40° C. stringent wash (five-fold). This observation is attributed to the enhanced dehybridization of the MM duplexes by AuNPs. On the other hand, increasing the stringent wash temperature from 22° C. to 40° C. enhanced the k.sub.d values of both MM duplexes and of PM duplexes, showing the undesirable destabilization of PM duplexes, in addition to the desirable destabilization of MM duplexes. These observations explain our findings obtained in the CD-NBA chip that the PM signals are not affected as much as the MM counterparts in the AuNP wash method, because of the enhanced destabilization of the MM duplex, but not of the PM duplex, leading to the preservation of the signal.
TABLE-US-00001 TABLE 1 Dehybridization rate constants (k.sub.d) of PM duplexes and MM duplexes using stringent wash and AuNP wash, as determined from SPR spectroscopy (See FIG. 10). Stringent wash AuNP Wash 22° C. 40° C. 22° C. k.sub.d/ PM 1.7 (±0.3).sup.a 8.1 (±0.8) 3.0 (±0.7) (10.sup.−4 s.sup.−1) MM 3.2 (±0.7) 18.7 (±0.9) 15.9 (±1.3) .sup.aAll standard errors are determined from two measurements each including five different target concentrations of 10, 20, 40, 80 and 160 nM.
[0059] We attribute the difference in enhanced destabilization of the MM duplexes, observed for AuNP wash, compared to stringent wash, to the specific mechanism on which the AuNP wash technique is based. During dehybridization, AuNPs bind to the ssDNA segments (bubbles), which have constantly formed by thermal breathing. The presence of a mismatch base pair, through a cooperative effect, causes weakening and disruption of the neighboring base pairs. In 2006, Zeng and coworkers compared the dissociation curves obtained from PM and MM duplexes, and found that the amount of bubbles was drastically enhanced in the presence of a single MM site in the middle of the duplex. The greater amount of bubbles in the MM duplexes makes them susceptible to the binding by AuNPs, leading to the success of the AuNP wash method. The AuNP wash method target these bubbles in MM duplexes for their enhanced dehybridization or destabilization, to a much larger extent than in the case of PM duplexes. This targeted mechanism of destabilization of MM duplexes causes an enhancement in the specificity without reducing the signal, leading to the observed low negative r value or almost no anticorrelation between signal and specificity. On the other hand, the stringent wash method has similar destabilizing influences on both of the PM and MM duplexes, which lead to their similar extent of accelerated dehybridization and the observed high signal/specificity anticorrelation, or high negative r value.
[0060] The preserved sensitivity upon enhancement of specificity is an exclusive feature of the AuNP wash method. This feature was not achieved in the previous AuNP-enabled method, in which AuNP was used in the hybridization step but not in the wash step. In the previous method, the hybridization signals obtained from DNA targets that are conjugated to AuNPs (AuNP targets) were observed to be lower than the signals from free targets, and this observation is attributed to the low hybridization rate constants (k.sub.h) of DNA targets, when conjugated to AuNPs. The experiment has been repeated in the CD-NBA chip and shown in
Optimization of the AuNP Wash Method
[0061] In order to optimize the AuNP wash method, we evaluate the effect of different experimental factors including the salt content of the buffer medium, the length and concentration of the oligonucleotide stabilizer (used to prevent AuNPs in the wash buffer to aggregate) on the performance of the method. Optimization of these factors can improve the effectiveness of AuNP destabilization of MM duplexes, and thus the efficacy of the method.
[0062] The histogram in
[0063] Using the data in
[0064] In order to stabilize AuNPs in the wash buffer against salt-induced aggregation, the AuNP crusts have been loaded with oligonucleotide stabilizers with sequences non-complementary to the probe/target sequences. The aggregation would have happened to the pristine nanoparticles due to high salt contents in the wash buffer. Here, we investigate the effects of length and concentration of the oligonucleotide stabilizers on the specificities obtained in the AuNP wash method.
Applications for Genomic Samples
[0065] In order to investigate the applicability of the AuNP wash technique for use with genomic samples, we first evaluated the robustness of the technique upon sequence variation (i.e. the purine content), and then we evaluated the performance of the technique using PCR amplicons as the target strands.
[0066] In order to evaluate the robustness of the AuNP wash technique, we employ 3 sequences related to KRAS gene (A20, A60, W20), and two sequences related to a fungal pathogen (B21, NB21); see Table 2. In W20 and A60 targets, the 20 bases of the target that hybridize with the probes are similar to A20 except for variations in the type of the mismatch base-pair (C-C base-pair in A20 and A60 vs. G-G in W20) and also in the length of the target (60 bases in A60 vs. 20 bases in A20). As shown in
[0067] We have also used the AuNP wash method to detect single nucleotide polymorphisms (SNPs) in genomic samples, which consists of 4 different alleles of KRAS gene codon 12. The detection of these SNPs is critical for clinicians to choose the appropriate type of therapy for colorectal cancer patients [31].
[0068] We have developed a technique for the enhancement of the specificity of DNA hybridization without reducing the signal. This technique is called AuNP wash, which may be performed in a CD-NBA chip using a buffer solution containing 5-nm gold nanoparticles (AuNPs). The solution dynamically washes the duplexes on the surfaces of the spiral channel of the chip and destabilizes the MM duplexes but not the PM duplexes. The nanoparticle does not bind to the fully coiled duplex, but does only target the ssDNA segments (bubbles) of the duplex in the course of dehybridization and accelerate the propagation of the bubbles and unzipping of the duplex. This mechanism of destabilization causes a preferential removal of the MM duplexes, rather than the PM ones, and hence the signal is preserved, while the specificity is enhanced. We have also studied the influence of several governing factors of the method, evaluated the performance of the technique upon the variation of the DNA sequences, and applied the method for detection of KRAS gene SNP variations in genomic samples. Furthermore, the SNP discrimination is achieved at a single temperature, alleviating the difficulty of temperature optimization for multiple targets of different melting temperatures in multiplex analysis. In contrast to the other attempts (e.g. molecular beacons) to enhance the specificities of DNA hybridization, no complicated design for the DNA probe sequence is required and high specificity is effectively achieved via a simple wash step subsequent to DNA hybridization. This simplicity is an advantage which, together with the robustness upon sequence variation and compatibility with multiplex analyses, makes this technique a promising tool to be used in DNA hybridization-based microarrays with the potential to reduce false positive/false negative results and improve the accuracy of the microarray results.
[0069] Other than hybridization, for DNA amplification we have developed the nanoparticle-assisted helicase-dependent amplification (HDA), termed nanoHDA, by enhancing the efficiency of conventional HDA using AuNPs. The nanoHDA technique is then coupled to our AuNP-enhanced technique for detection of SNPs in the KRAS gene. To the best of our knowledge, this is the first report on the use of nanoparticles for improving an isothermal amplification technique.
[0070]
[0071] We attribute low HDA signals on lane 3 to the low efficiency of helicases to denature long dsDNA templates, which may cause HDA to fail in amplifying long gDNA, but not short ssDNA. In contrast, PCR is successful (lane 5) because it denatures the template by heating, which is capable of quickly denaturing even long dsDNA. To overcome the issue of DNA length, we treated the gDNA template with the restriction enzyme NlaIII (New England Biolabs) to generate DNA fragments of reduced lengths. This restriction enzyme was chosen to perform a digestion and create a 240-bp fragment which contains the KRAS sequence. Lanes 4 and 6 show the results of improved intensities for the HDA amplicons obtained from the 240-bp restriction fragment. These results are consistent with the previous report by Tong et al. that the use of a restriction enzyme as an additive in the HDA reagents improved the amplification of a bacterial DNA [29].
[0072] These improved results in lanes 4 and 6 also confirm our hypothesis that the HDA efficiency for long DNA templates is low because of the limited capability of helicase-mediated template denaturation. However, the improved signal is still not comparable to the signal obtained from the HDA amplicons generated from the 162-gene fragment template (lane 2). As inspired from the use of nanoparticles in PCR, we added gold nanoparticles (AuNPs) in the HDA reagents to assist in the helicase-mediated denaturation of templates, a new method we dubbed nanoHDA. The hybridization signals in Lanes 8 and 9, which were obtained from HDA on gDNA with AuNP added to the amplification mixture. Even when AuNPs were used, the template should still be digested with the restriction enzyme, as seen from the low intensity in Lane 7 when only AuNP but not restriction enzymes was used. A comparison between the signals in lanes 8 and 9 shows that the use of different sized AuNPs (5 nm, 10 nm, respectively) has a similar enhancing effect on HDA. On the basis of these results, we speculate two ways that AuNPs assist helicases in dsDNA denaturation and thus enhance HDA. First, AuNPs may have a preferential affinity for ssDNAs versus dsDNAs. Thus in a similar fashion to that of single-stranded binding (SSB) protein, nanoparticles may bind to the ssDNA segments and prevent them from renaturation, which assists the helicase-dependent denaturation. Second, AuNPs may be able to directly affect the dsDNA segments and enhance their denaturation [21, 58, 59], a capability that has not been reported for SSB protein. Once bound to a partially denaturated DNA, AuNPs destabilize the neighbouring base-pairs and accelerate denaturation of the dsDNA segments.
[0073] To examine if a greater number of AuNPs enhance HDA even more, we studied the effect of different amounts of AuNPs on nanoHDA.
[0074] To confirm if HDA inhibition at high AuNPs concentration is due to a loss of HDA enzymes on the nanoparticle crusts, different enzyme mix concentrations were used and the results were compared. As shown in
[0075] NanoHDA also reduced the nonspecific amplification of primer-dimers. Their formation is evidenced in the results of the primer-dimer peaks obtained using capillary gel electrophoresis (CGE). As shown in
[0076] A comparison between the kinetics of HDA and nanoHDA was also conducted on the NBA chip to further understand the effect of nanoparticles on enhancing HDA.
[0077] A property resulted from the interaction between DNA bases and nanoparticles is used to enhance the reaction efficiency of PCR, as reported by several groups, and different mechanisms were proposed for this enhancement effect [51, 52]. First, Li et al. suggested that the preferential binding of single-stranded DNA (ssDNA) to AuNP surfaces, in a manner similar to single-strand binding protein (SSB), increased the specificity and sensitivity of PCR [53]. Second, the excellent heat-transfer property of nanoparticles is proposed to have shortened the reaction time for PCR [54], but this idea was later criticized by others [55]. Furthermore, Mi et al. suggested that AuNPs modulated the polymerase activity and enabled a hot start-like effect that suppressed nonspecific amplification at low temperature [56]. As inspired by these reports, we try to further enhance our nanoHDA technique by reducing the temperature from 65° that is used in conventional thermophilic HDA. However, we observe a significant signal reduction as the nanoHDA temperature decreases from of 65° to 40° (See
[0078] The nanoHDA technique provides an efficient platform for amplification of human genomic DNAs for subsequent hybridization-based detections. Therefore, we aim to combine nanoHDA with our AuNP-wash method to enable SNP detection using nanobioarray (NBA) chips. This combination allows for high-throughput SNP genotyping of the human genome. In the combined method, the amplicons were first prepared by a 1-h amplification using nanoHDA (10 nm AuNP, 0.3 nM) from 1 ng of gDNA with different alleles of KRAS gene. Thereafter, the HDA amplicons hybridized to an array of surface-bound oligonucleotide probes on the surface of an NBA chip, and finally the mismatched DNA duplexes were removed using the AuNP-wash method. As indicated by high sensitivity and specificity of the signals in
[0079] In conclusion, we used gold nanoparticles (AuNPs) to improve sensitivity and specificity of helicase-dependent amplification (HDA). Our results show that preferential binding of nanoparticles to ssDNA facilitates helicase-mediated DNA denaturation and hence accelerates HDA and improves amplification sensitivity. In the presence of nanoparticles, the formation of primer-dimers were also suppressed which contributed to the high specificity of the technique. Finally, we successfully demonstrated SNP detection on human gDNA samples by coupling the nanoHDA technique with the AuNP-enhanced hybridization technique.
Experimental Section
Materials
[0080] Gold nanoparticles (with citrate and tannic acid) of 5-, 10- and 20-nm diameter were purchased from Sigma Life Science and 12-nm diameter gold nanoparticles (capped with citrate) were obtained from NanoComposix (San Diego, Calif.). Sodium dodecyl sulphate (SDS), 3-aminopropyltriethoxysilane (APTES), 25% glutaraldehyde, cetyltrimethylammonium bromide (CTAB) and Triton X-100 were purchased from Sigma-Aldrich. Negative photoresist (SU-8 50) and its developer were purchased from MicroChem Corp. (Newton, Mass.). Circular glass chips with 4-in. diameter and a 0.6-in. centre hole were obtained from Precision Glass & Optics (Santa Ana, Calif., USA).
[0081] All the reagents and materials required for surface plasmon resonance (SPR) experiments including 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), N-hydroxysuccinimide (NHS), ethanolamine, HBS-N Buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl) and CMS sensor chips, were provided by GE Healthcare (UK).
[0082] All oligonucleotides (listed in Table 2) were synthesized and modified by Integrated DNA Technologies (Coralville, Iowa). Target oligonucleotides (20- or 60-mer) representing different SNPs of KRAS gene codon 12 (G12A (A) and wild-type (W)) and also 20-mer of B and NB targets (fungal pathogenic sequences [32]) were modified with a biotin molecule at the 5′-end. The probe sequences were designed in such a way that the SNP sites were located at the centre of the oligonucleotides. The 20-mer probe oligonucleotides were modified with an amine group and a C12 spacer at the 5′-end.
TABLE-US-00002 TABLE 2 The sequences of probe, target and primer oligonucleotides. The underlined region of A60 is identical to the sequence of A20. The underlined sequence of A60 is the same as that of A20. name sequence Targets W20 5′-/biotin/GTT GGA GCT GGT GGC GTA GG-3′ A20 5′-/biotin/GTT GGA GCT GCT GGC GTA GG-3′ D20 5′-/biotin/GTT GGA GCT GAT GGC GTA GG-3′ V20 5′-/biotin/GTT GGA GCT GTT GGC GTA GG-3′ A60 5′-/biotin/GAA TAT AAA CT T GTG GTA GTT GGA GCT GCT GGC GTA GGC AAG AGT GCC TTG ACG ATA CAG-3′ C-W20 5′-/Cy5/GTT GGA GCT GGT GGC GTA GG-3′ B21 5′-/Cy5/GAG TTT TGG TAT TCT CTG GCG-3′ NB21 5′-/Cy5/GAG TTT TGG TTT TCT CTG GCG-3′ Probes W 5′-/C12amine/CC TAC GCC ACC AGC TCC AAC-3′ A 5′-/C12amine/CC TAC GCC AGC AGC TCC AAC-3′ D 5′-/C12amine/CC TAC GCC ATC AGC TCC AAC-3′ V 5′-/C12amine/CC TAC GCC AAC AGC TCC AAC-3′ AB 5′-/C12amine/CGC CAG AGA ATA CCA AAA CTC-3′ ANB 5′-/C12amine/CGC CAG AGA ATA CCA AAA CTC-3′ Primers Forward- 5′-biotin-TGA CTG AAT ATA AAC TTG TGG TAG TTG GAG-3′ for 80-bp 80 bp KRAS Reverse- 5′-ATG ATT CTG AAT TAG CTG TAT CGT CAA GGC -3′ amplicon 80 bp
[0083] The genomic DNA samples, containing different allele compositions of the KRAS gene codon 12 were obtained from QIMR Berghofer Medical Research Institute (Brisbane, Australia). In order to obtain the 80-bp PCR products, a pair of forward and reverse primers (See Table 2) was used. A custom PCR protocol on a thermocycler (Cetus, Perkin Elmer) was used for DNA amplification. The thermocycling was initiated by 3 minutes of denaturation, followed by 30 thermal cycles of 95° C. for 40 s (denaturation), 55° C. for 30 s (annealing) and 72° C. for 60 s (extension), and terminated by 10 minutes of final extension at 72° C. The amplified products were purified using a nucleotide removal kit form Qiagen Inc. (Toronto, ON, Canada).
DNA Hybridization in a CD-NBA Chip
[0084] The CD-NBA chip comprises of a PDMS slab (4 in. diameter) with 96 radial microchannels, sealed reversibly to a circular glass chip. The width of straight radially arranged channels was 200 μm and the height was 35 μm. The probe immobilization procedure was similar to the previously reported methods [19, 64, 65]. Briefly, 0.5 μL of probe solution (in 1.0M NaCl+0.15M NaHCO.sub.3) was added to the inlet reservoirs of the CD-NBA chip, and it was placed on a rotating platform. The solutions were introduced into the radial channels by spinning the circular chip at 400 rpm for 3 min. The probe solutions were driven out from the channel after 20 min. of incubation at room temperature by spinning the chip at 1800 rpm for 1 min. Subsequently, the radial PDMS slab was peeled off, leaving behind 96 radial probe lines printed on the glass chip, which was then rinsed and dried. Thereafter, another PDMS slab with 96 spiral channels was sealed against the glass chip pre-printed with the probe lines to carry out the DNA hybridization. The target solution (1 μL), prepared in hybridization buffer (1×SSC+0.2% SDS) with a final concentration of 10 nM, was added to the inlet reservoir and then flowed in the spiral channel (100 μm wide) using a spin rate of 900 rpm. This spin rate resulted in ˜13 min. of dynamic hybridization of the targets to the complementary probes at the intersections of spiral channels with the radially arrayed probe lines. High-temperature experiments were achieved by heating the CD-NBA chip using a hot air blower. The temperature was calibrated in a separate experiment using a temperature sensor placed on the glass chip surface, sealed with the PDMS slab to it.
[0085] The washing procedure was performed after DNA hybridization. The wash solution was SSC with NaCl concentrations that range from 10 to 300 mM. The washing buffer contained either no AuNPs or AuNPs of various concentrations from 0.2 to 40 nM. In order to stabilize the AuNPs against salt aggregation, they were loaded with DNA oligonucleotides, with sequences irrelevant to the target strands, prior to addition to the wash buffer. This was performed by mixing various concentrations of 12- or 20-mer oligonucleotide with AuNPs and incubating the mix at 95° C. for 5 min. Afterwards, 2 μL of the AuNP wash buffer was added to the inlet reservoirs of the spiral channels. Dynamic wash was performed by spinning the CD-NBA chip at spinning rates of 700 to 1500 rpm. Stop-flow wash was performed by spinning the chip at 2200 rpm for 20 s in order to fill the channels with the wash buffer, incubating for 15 min. (stop-flow), and then ejecting the buffer with a spin rate at 2200 rpm for another 20 s. After washing (dynamic or stop-flow) was completed, streptavidin-Cy5 solution (50 μg/ml in 1×PBS buffer) was added to the inlet reservoir and allowed to flow in the channel by spinning at 1500 rpm. Finally, the spiral PDMS slab was peeled off from the glass chip.
[0086] The fluorescence detection was carried out by scanning the glass chip on a confocal laser fluorescent scanner (Typhoon 9410, GE Healthcare) at 10 μm resolution, as previously described [20, 22]. The excitation and emission wavelengths were 633 and 670 nm, respectively. The photomultiplier tube voltage was set at 600 V. The scanned image was analysed by IMAGEQUANT 5.2 software.
DNA Adsorption on AuNPs
[0087] In order to study the kinetics of adsorption of DNA oligonucleotides on the surface of AuNPs, the fluorescence quenching measurement was conducted. Cy5-labeled W20 oligonucleotides (8 nM) were prepared in 1 ml of sodium citrate buffer (15 mM) in a polystyrene cuvette. The buffer contained NaCl concentrations of 0, 10, 30, 50, 70, 90, 110, 130 and 150 mM. The cuvette was placed in the holder of a spectrofluorometer (Photon Technology International). Thereafter, 1 ml of aqueous AuNP colloid (80 nM) was added to the cuvette and the content was mixed. Immediately after, the fluorescence intensity (excitation at 650 nm and emission at 670 nm) was monitored for 7 min. using the time-based mode.
Surface Plasmon Resonance (SPR) Spectroscopy
[0088] The SPR measurements were performed on BIAcore X100 (GE Healthcare) as previously reported [21]. Briefly, the immobilisation of the amine-labelled 20-mer probes (A) was performed on the surface of a sensor chip (CMS), using a company-developed method [21, 33]. The carboxylic groups on the sensor surface were activated by an EDC/NHS mixture (1:1 v/v). Then, the amine-labeled probe molecules were immobilized on the sensor surface by running the immobilization solution containing the probe molecules (50 μM) and CTAB (0.6 mM) over the sensor surface. Finally, unreacted succinimide groups were deactivated using an ethanolamine solution (pH 8.5). The target solutions were prepared in the HBS-N buffer with DNA target concentrations of 10, 20, 40, 80 and 160 nM. The rate constants of DNA hybridization and dehybridization were determined using the multi-cycle kinetic procedure. Briefly, 10 nM target solutions were first continuously flowed for 60 s over the sensor chip surface (with immobilized probe). After hybridization, washing was achieved by a continuous flow of wash buffer over the sensor surface for 240 s. In the stringent wash experiment, the HBS-N buffer was used as the wash buffer. However, the AuNP wash buffer contain 5-nm AuNPs (10 nM) in the HBS-N buffer. The nanoparticles in the AuNP wash buffer had been previously loaded with the 20-mer oligonucleotides (stabilizers with a sequence unrelated to the target and probe), by mixing the stabilizers with AuNPs in water and then incubating the mix at 95° C. for 5 min. After each hybridization-wash cycle, the sensor surface was regenerated (all the target strands were washed away) by running an alkaline wash (50 mM NaOH) for 30 s. This cycle of hybridization, wash and regeneration was repeated for the other 4 target concentrations of 20, 40, 80, 160 nM.
Helicase-Dependent Amplification (HDA) and nanoHDA
[0089] All probe oligonucleotides, primers and gBlocks Gene Fragments (listed in Tables 2 and 3) were synthesized and modified by Integrated DNA Technologies (Coralville, Iowa). In order to obtain the 92-bp PCR products, a pair of forward and reverse primers (See Table 3) was used.
TABLE-US-00003 TABLE 3 the sequences of primers and probes used in HDA, nanoHDA and DNA hybridization in the NBA chip. b-DNA Forward 5′-/biotin/AGC CGA ATT CAA AAC ATC GTA ACT (Positive primer-b102 GAG-3′ HDA Reverse 5′-AAT ATT TTC CAA CAA CGCTTC TGC AAT-3′ Control) primer-b102 Probe-b102 5′-/C12amine/TGG CCT CTC AAT GCT TTT TC-3′ for 92-bp Forward 5′-/biotin/TTA TAA GGC CTG CTG AAA ATG ACT KRAS primer-92 bp GAA-3′ amplicons Reverse 5′-TGA ATT AGC TGT ATC GTC AAG GCA CTC-3′ primer-92 bp 162-bp 5′-CAT TAT TTT TAT TAT AAG GCC TGC TGA gBlock® AAA TGA CTG AAT ATA AAC TTG TGG TAG Gene TTG GAG CTG GTG GCG TAG GCA AGA GTG Fragments CCT TGA CGA TAC AGC TAA TTC AGA ATC ATT TTG TGG ACG AAT ATG ATC CAA CAA TAG AGG TAA ATC TTG TTT TAA TAT GCA-3′
[0090] All the reagents for HDA and also the b-DNA template were purchased from Biohelix Corporation (Beverly, Mass., USA). Taq DNA polymerase and PCR dNTP mix were purchased from Thermo Fisher Scientific (Waltham, Mass.). The restriction enzyme NlaIII was purchased from New England Biolabs (Ipswich, Mass.).
[0091] To setup a 25 μL of 1×HDA reaction, 2.5 μL of 10× annealing buffer, 0.75 μL of 100 mM MgSO.sub.4, 2.5 μL of 500 mM NaCl, 1.75 μL of IsoAmp dNTP solution (200 μM dNTPs, 3 mM dATP), 1 μL of IsoAmp III enzyme mix 1 ng of DNA template, 0.75 μL of forward and reverse primer (2.5 μM), and 12.75 μL ddH.sub.2O were pipetted into a 0.2 mL centrifuge tube. The enzyme mix consisted of 10 U of polymerase (an analog of Bst that doesn't have 3′-5′ exonuclease activity), 50 ng of helicase (Tte-UvrD), 200 ng Tte-MutL (a cofactor of helicase that stimulates and enhances the unwinding performance), and 25 ng ET-SSB, The HDA reaction mixture was briefly vortexed, followed by 30 s centrifugation at 1500 g. The HDA reaction mixture was then overlayed with 50 μL of silicone oil and incubated for 120 min (unless otherwise noted) in a water bath at 65° C. For nanoHDA experiments different amounts of AuNPs were added to the forward primer solution and the mix was kept overnight before being added to the HDA mix. The amplified products were purified using a nucleotide removal kit (Qiagen, Hilden, Germany).
Polymerase Chain Reaction (PCR)
[0092] PCR amplification was performed on a thermocycler (Cetus, Perkin Elmer), as previously described [19]. To setup a 50 μL of 1× reaction, 5 μL of 10×PCR buffer, 3 μL of 50 mM MgCl.sub.2, 5 μL of dNTP mix (2 mM each dNTP), 0.5 μL Taq DNA polymerase solution (1.25 U), 1 ng of DNA template, 8 μL of forward and reverse primer (2.5 μM), and 19.5 μL ddH.sub.2O were pipetted in a 0.2 mL centrifuge tube, mixed by a brief vortex followed by 30 s centrifugation at 1500 g. The thermocycling was initiated by 3 min of denaturation, followed by 30 thermal cycles of 94° C. for 40 s (denaturation), 65° C. for 30 s (annealing) and 72° C. for 60 s (extension), and terminated by 10 min of final extension at 72° C. The amplified products were purified using a nucleotide removal kit (Qiagen).
Capillary Gel Electrophoresis (CGE)
[0093] All the CGE experiments were performed on Bioanalyzer 2100 (Agilent Technologies, Santa Clara, Calif.). A DNA 1000 kit was used to analyze the 92-bp amplicons. Briefly, 1 μL of purified amplicons were diluted 1:10 in ddH.sub.2O and added together with 5 μL of marker solution (low and higher markers) to the DNA chips. The electropherograms were obtained using the 2100 Expert software (Agilent Technologies). The chips may be cleaned and re-used, as previously described [66].
[0094] It is understood that the examples in the foregoing disclosure in no way serve to limit the scope of this invention, but rather are presented for illustrative purposes. As will be apparent to those skilled in the art in the light of the foregoing disclosure, many alterations and modifications are possible in the practice of this invention without departing from the scope thereof.
[0095] This invention has a wide range of aspects. Without limitation, the aspects include each of the following:
1. A nucleic acid hybridization method, comprising: [0096] (a) immobilizing probe nucleic acid molecules on a surface; [0097] (b) flowing target nucleic acid molecules to the immobilized probe nucleic acid molecules on said surface in a hybridization buffer solution; [0098] (c) washing said surface with a wash solution which comprises nanoparticles; and [0099] (d) detecting the presence of duplexes on said surface comprising a strand of one of said target nucleic acid molecules and a strand of one of said probe nucleic acid molecules.
2. The method according to aspect 1, wherein the nanoparticles are generally spherical in shape.
3. The method according to aspect 1 or 2, wherein the nanoparticles are sized between 1 and 10 nanometers.
4. The method according to aspect 3, wherein the nanoparticles are sized between 3.5 to 6.5 nanometers.
5. The method according to aspect 4, wherein the nanoparticles have an average diameter of about 5 nanometers.
6. The method according to any one of aspects 1 to 5, wherein the nanoparticles are coated with negative charged ions.
7. The method according to aspect 6, wherein the nanoparticles are coated with citrate.
8. The method according to any one of aspects 1 to 7, wherein surfaces of the nanoparticles are loaded with oligonucleotide stabilizers whose sequences are irrelevant with respect to the sequences of the probe nucleic acid molecules or the target nucleic acid molecules.
9. The method according to aspect 8, wherein the length of the oligonucleotide stabilizers is 20-mer or shorter.
10. The method according to aspect 9, wherein the length of the oligonucleotide stabilizers is 15-mer or shorter.
11. The method according to aspect 10, wherein the length of the oligonucleotide stabilizers is 12-mer.
12. The method according to any one of aspects 1 to 11, wherein the concentration of the nanoparticles in the wash solution is in a range of 2 to 20 nM.
13. The method according to any one of aspects 1 to 12, wherein the concentration of NaCl in the wash solution is in a range of 50 to 300 nM.
14. The method according to any one of aspects 1 to 12, wherein the wash solution has an ionic strength equivalent to NaCl concentration of between 50 and 150 nM.
15. The method according to any one of aspects 1 to 14, wherein the washing step is performed at an ambient temperature.
16. The method according to any one of aspects 1 to 14, wherein the washing step is performed at a temperature below 30° C.
17. The method according to aspect 16, wherein the washing step is performed at a temperature between 20° C. and 25° C.
18. The method according to any one of aspects 1 to 17, wherein said surface is formed from a material selected from the group consisting of glass, silicon, plastic, polymer and cellulose.
19. The method according to any one of aspects 1 to 18, wherein the probe nucleic acid molecules comprise single-stranded DNA or oligonucleotides.
20. The method according to any one of aspects 1 to 19, wherein the target nucleic acid molecules are conjugated with a detectable label.
21. A method for distinguishing two target nucleic acid molecules whose nucleotide sequences differ by at least one nucleotide, the method comprising:
carrying out two separate nucleic acid hybridization assays in parallel, the first assay with a first target and a probe, the second assay with a second target and the same probe, each assay comprising: [0100] (a) providing a sample solution comprising a target nucleic acid; [0101] (b) incubating said sample solution with probe nucleic acid molecules immobilized on a surface; [0102] (c) washing said surface with a wash solution which comprises nanoparticles; and [0103] (d) detecting the presence of target:probe duplex on the surface;
whereby the two target nucleic acid molecules are distinguished by different degrees of hybridization to the probe.
22. A microarray method comprising: [0104] (a) providing a solid support; [0105] (b) immobilizing a plurality of nucleic acid probes at discrete positions on the support; [0106] (c) exposing a sample solution to the probes, the sample solution comprising sample nucleic acid molecules; [0107] (d) washing off the sample solution with a wash solution which comprises nanoparticles; and [0108] (e) determining the degree of hybridization between the sample molecules and the probes.
23. A method of using a microfluidic microarray assembly (MMA) comprising:
(a) providing a test chip;
(b) providing a first channel plate sealingly connectable to said test chip for applying at least one probe reagent to said test chip, wherein said first channel plate comprises a plurality of first microfluidic channels configured in a first predetermined reagent pattern;
(c) assembling said first channel plate to said test chip;
(d) flowing said at least one probe reagent through said first microfluidic channels to form a first array of said at least one probe reagent on said test chip in said first predetermined reagent pattern;
(e) immobilizing said at least one probe reagent on said test chip;
(f) removing said first channel plate from said test chip;
(g) providing a second channel plate sealingly connectable to said test chip for applying at least one sample reagent to said test chip, wherein said second channel plate comprises a plurality of second microfluidic channels configured in a second predetermined pattern differing from said first predetermined pattern;
(h) assembling said second channel plate to said test chip;
(i) flowing said at least one sample reagent through said second microfluidic channels to form a second array, wherein said second array intersects said first array at said test locations;
(j) flowing a wash solution which comprises nanoparticles through said second microfluidic channels; and
(k) detecting any hybridization products at said test locations.
24. The method according to aspect 23, wherein said at least one probe reagent comprises a plurality of different probes, wherein each of said probes is flowable through separate ones of said first microfluidic channels.
25. The method according to aspect 23 or 24, wherein said at least one sample reagent comprises a plurality of different test samples, wherein each of said samples is flowable through separate ones of said second microfluidic channels.
26. The method according to any one of aspects 23 to 25, wherein one of said first and second predetermined reagent patterns is a radial pattern and the other of said first and second predetermined reagent patterns is a spiral pattern.
27. The method according to any one of aspects 23 to 26, wherein the nanoparticles are generally spherical in shape.
28. The method according to any one of aspects 23 to 27, wherein the nanoparticles are sized between 1 and 10 nanometers.
29. The method according to aspect 28, wherein the nanoparticles are sized between 3.5 to 6.5 nanometers.
30. The method according to aspect 29, wherein the nanoparticles have an average diameter of about 5 nanometers.
31. The method according to any one of aspects 23 to 30, wherein the nanoparticles are coated with negative charged ions.
32. The method according to aspect 31, wherein the nanoparticles are coated with citrate.
33. The method according to any one of aspects 23 to 32, wherein surfaces of the nanoparticles are loaded with oligonucleotide stabilizers whose sequences are irrelevant with respect to the sequences of the probes or the samples.
34. The method according to aspect 33, wherein the length of the oligonucleotide stabilizers is 20-mer or shorter.
35. The method according to aspect 34, wherein the length of the oligonucleotide stabilizers is 15-mer or shorter.
36. The method according to aspect 35, wherein the length of the oligonucleotide stabilizers is 12-mer.
37. The method according to any one of aspects 23 to 36, wherein the concentration of the nanoparticles in the wash solution is in a range of 2 to 20 nM.
38. The method according to any one of aspects 23 to 37, wherein the concentration of NaCl in the wash solution is in a range of 50 to 300 nM.
39. The method according to any one of aspects 23 to 37, wherein the wash solution has an ionic strength equivalent to NaCl concentration of between 50 and 150 nM.
40. The method according to any one of aspects 23 to 39, wherein the washing step is performed at an ambient temperature.
41. The method according to any one of aspects 23 to 39, wherein the washing step is performed at a temperature below 30° C.
42. The method according to aspect 41, wherein the washing step is performed at a temperature between 20° C. and 25° C.
43. The method according to any one of aspects 23 to 42, wherein said test chip is formed from a material selected from the group consisting of glass, silicon, plastic, polymer and cellulose.
44. The method according to any one of aspects 23 to 43, wherein the probes comprise single-stranded DNA or oligonucleotides.
45. The method according to any one of aspects 23 to 44, wherein the samples are conjugated with a detectable label.
46. The method according to any one of aspects 1 to 45, wherein the nanoparticles comprise metal nanoparticles.
47. The method according to any one of aspects 1 to 45, wherein the nanoparticles comprise non-metal nanoparticles.
48. The method according to any one of aspects 1 to 45, wherein the nanoparticles comprise gold nanoparticles.
49. The method according to any one of aspects 1 to 45, wherein the nanoparticles comprise silver nanoparticles.
50. An isothermal nucleic acid amplification method, the method comprising:
(i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles,
(ii) allowing the substrate nucleic acid molecules to be denatured by the helicase,
(iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules,
(iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to form duplex products, and
(v) repeating steps (a) through (d) for a plurality of cycles to amplify the substrate nucleic acid molecules,
wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products.
51. The method according to aspect 50, further comprising digesting the substrate nucleic acid molecules with a restriction enzyme prior to step (i).
52. The method according to aspect 5, wherein the substrate nucleic acid molecules are digested with a restriction enzyme to fragment sizes of less than 500 bp.
53. The method according to aspect 6, wherein the substrate nucleic acid molecules are digested with a restriction enzyme to fragment sizes of less than 300 bp.
54. The method according to any one of aspects 50 to 53, wherein the concentration of the nanoparticles in the reaction solution is in a range of 0.1 to 10 nM.
55. The method according to any one of aspects 50 to 54, wherein the nanoparticles in the reaction solution have an average diameter of about 5 to 10 nanometers.
56. The method according to any one of aspects 50 to 55, wherein the steps (i) through (v) are carried out at a constant reaction temperature.
57. The method according to aspect 56, wherein the constant reaction temperature is in a range of 40 to 70° C.
58. The method according to aspect 57, wherein the constant reaction temperature is about 65° C.
59. The method according to any one of aspects 50 to 58, wherein the oligonucleotide primers are a pair of oligonucleotide primers wherein one primer hybridizes to a first end and one primer hybridizes to a second end of the substrate nucleic acid to be amplified.
60. The method according to any one of aspects 50 to 59, wherein the helicase comprises a plurality of helicases.
61. The method according to aspect 60, wherein the helicases comprise a 3′ to 5′ helicase, a 5′ to 3′ helicase, or both.
62. The method according to any one of aspects 50 to 61, wherein the reaction solution comprises a single strand binding (SSB) protein.
63. The method according to any one of aspects 50 to 62, wherein the polymerase is a Klenow fragment of E. coli DNA polymerase I, T7 DNA polymerase, Bst polymerase large fragment, or a homolog thereof.
64. The method according to any one of aspects 1 to 20, wherein the target nucleic acid molecules are amplified using an isothermal nucleic acid amplification method, the amplification method comprising:
(i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles,
(ii) allowing the substrate nucleic acid molecules to be denatured by the helicase,
(iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules,
(iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to form duplex products, and
(v) repeating steps (i) through (iv) for a plurality of cycles to amplify the substrate nucleic acid molecules,
wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products, and
wherein the concentration and other parameters of the nanoparticles in the amplification method and the washing step in the hybridization method are independently optimized.
65. The method according to aspect 22, wherein the sample nucleic acid molecules are amplified using an isothermal nucleic acid amplification method, the amplification method comprising:
(i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles,
(ii) allowing the substrate nucleic acid molecules to be denatured by the helicase,
(iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules,
(iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to form duplex products, and
(v) repeating steps (i) through (iv) for a plurality of cycles to amplify the substrate nucleic acid molecules,
wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products, and
wherein the concentration and other parameters of the nanoparticles in the amplification method and the washing step in the hybridization method are independently optimized.
66. The method according to aspect 23, wherein said at least one sample reagent comprises nucleic acid molecules which are amplified using an isothermal nucleic acid amplification method, the amplification method comprising:
(i) providing substrate nucleic acid molecules in a reaction solution which comprises a helicase, a polymerase, dNTPs, oligonucleotide primers, and nanoparticles,
(ii) allowing the substrate nucleic acid molecules to be denatured by the helicase,
(iii) allowing the oligonucleotide primers to anneal to the denatured substrate nucleic acid molecules,
(iv) allowing the polymerase to extend the annealed primers to synthesize complementary nucleic acid strands to form duplex products, and
(v) repeating steps (i) through (iv) for a plurality of cycles to amplify the substrate nucleic acid molecules,
wherein the presence of the nanoparticles in the reaction solution enhances the denaturation of the substrate nucleic acid molecules and increases the amount of the amplified products, and
wherein the concentration and other parameters of the nanoparticles in the amplification method and the washing step in the hybridization method are independently optimized.
REFERENCES
[0109] 1. V. Gubala, L. F. Harris, A. J. Ricco, M. X. Tan and D. E. Williams, Point of care diagnostics: status and future. Analytical chemistry, 2011, 84, 487-515. [0110] 2. A. Niemz, T. M. Ferguson and D. S. Boyle, Point-of-care nucleic acid testing for infectious diseases. Trends in biotechnology, 2011, 29, 240-250. [0111] 3. K. Knez, D. Spasic, K. P. Janssen and J. Lammertyn, Emerging technologies for hybridization based single nucleotide polymorphism detection. Analyst, 2014, 139, 353-370. [0112] 4. H. Koltai and C. Weingarten-Baror, Specificity of DNA microarray hybridization: characterization, effectors and approaches for data correction. Nucleic acids research, 2008, 36, 2395-2405. [0113] 5. A. Chagovetz and S. Blair, Real-time DNA microarrays: reality check. Biochemical Society Transactions, 2009, 37, 471-475. [0114] 6. C. T. Wittwer, High-resolution DNA melting analysis: advancements and limitations. Human mutation, 2009, 30, 857-859. [0115] 7. H. Urakawa, S. El Fantroussi, H. Smidt, J. C. Smoot, E. H. Tribou, J. J. Kelly, P. A. Noble and D. A. Stahl, Optimization of single-base-pair mismatch discrimination in oligonucleotide microarrays. Applied and environmental microbiology, 2003, 69, 2848-2856. [0116] 8. L. A. Marcelino, V. Backman, A. Donaldson, C. Steadman, J. R. Thompson, S. P. Preheim, C. Lien, E. Lim, D. Veneziano and M. F. Polz, Accurately quantifying low-abundant targets amid similar sequences by revealing hidden correlations in oligonucleotide microarray data. Proceedings of the National Academy of Sciences, 2006, 103, 13629-13634. [0117] 9. R. A. Rule, A. E. Pozhitkov and P. A. Noble, Use of hidden correlations in short oligonucleotide array data are insufficient for accurate quantification of nucleic acid targets in complex target mixtures. Journal of microbiological methods, 2009, 76, 188-195. [0118] 10. S. Michiels, S. Koscielny and C. Hill, Prediction of cancer outcome with microarrays: a multiple random validation strategy. The Lancet, 2005, 365, 488-492. [0119] 11. V. V. Demidov and M. D. Frank-Kamenetskii, Two sides of the coin: affinity and specificity of nucleic acid interactions. Trends in biochemical sciences, 2004, 29, 62-71. [0120] 12. L. Poulsen, M. J. Søe, D. Snakenborg, L. B. Møller and M. Dufva, Multi-stringency wash of partially hybridized 60-mer probes reveals that the stringency along the probe decreases with distance from the microarray surface. Nucleic acids research, 2008, 36, e132-e132. [0121] 13. J. Grimes, Y. V. Gerasimova and D. M. Kolpashchikov, Real-time SNP Analysis in Secondary-Structure-Folded Nucleic Acids. Angewandte Chemie, 2010, 122, 9134-9137. [0122] 14. D. M. Kolpashchikov, Binary malachite green aptamer for fluorescent detection of nucleic acids. Journal of the American Chemical Society, 2005, 127, 12442-12443. [0123] 15. D. M. Kolpashchikov, A binary DNA probe for highly specific nucleic acid recognition. Journal of the American Chemical Society, 2006, 128, 10625-10628. [0124] 16. S. A. Marras, F. R. Kramer and S. Tyagi, Efficiencies of fluorescence resonance energy transfer and contact-mediated quenching in oligonucleotide probes. Nucleic acids research, 2002, 30, e122-e122. [0125] 17. S. Tyagi and F. R. Kramer, Molecular beacons: probes that fluoresce upon hybridization. Nature biotechnology, 1996, 14, 303-308. [0126] 18. D. Y. Zhang, S. X. Chen and P. Yin, Optimizing the specificity of nucleic acid hybridization. Nature chemistry, 2012, 4, 208-214. [0127] 19. A. Sedighi and P. C. Li, KRAS gene codon 12 mutation detection enabled by gold nanoparticles conducted in a nanobioarray chip. Analytical biochemistry, 2014, 448, 58-64. [0128] 20. L. Wang and P. C. Li, Gold nanoparticle-assisted single base-pair mismatch discrimination on a microfluidic microarray device. Biomicrofluidics, 2010, 4, 032209, 1-9. [0129] 21. A. Sedighi, P. C. Li, I. C. Pekcevik and B. D. Gates, A Proposed Mechanism of the Influence of Gold Nanoparticles on DNA Hybridization. ACS Nano, 2014, 8, 6765-6777. [0130] 22. L. Wang and P. C. Li, Optimization of a microfluidic microarray device for the fast discrimination of fungal pathogenic DNA. Analytical biochemistry, 2010, 400, 282-288. [0131] 23. L. Wang, P. C. Li, H.-Z. Yu and A. M. Parameswaran, Fungal pathogenic nucleic acid detection achieved with a microfluidic microarray device. Analytica chimica acta, 2008, 610, 97-104. [0132] 24. J. Lee Rodgers and W. A. Nicewander, Thirteen ways to look at the correlation coefficient. The American Statistician, 1988, 42, 59-66. [0133] 25. A. Lomakin and M. D. Frank-Kamenetskii, A theoretical analysis of specificity of nucleic acid interactions with oligonucleotides and peptide nucleic acids (PNAs). Journal of molecular biology, 1998, 276, 57-70. [0134] 26. D. R. Kearns and T. L. James, NMR Studies of Conformational States and Dynamics of DN. Critical Reviews in Biochemistry and Molecular Biology, 1984, 15, 237-290. [0135] 27. T. Dauxois, M. Peyrard and A. Bishop, Entropy-driven DNA denaturation. Physical Review E, 1993, 47, R44-R47. [0136] 28. Y. Zeng and G. Zocchi, Mismatches and bubbles in DNA. Biophysical journal, 2006, 90, 4522-4529. [0137] 29. X. Zhang, M. R. Servos and J. Liu, Surface science of DNA adsorption onto citrate-capped gold nanoparticles. Langmuir, 2012, 28, 3896-3902. [0138] 30. L. M. Demers, M. Östblom, H. Zhang, N.-H. Jang, B. Liedberg and C. A. Mirkin, Thermal desorption behavior and binding properties of DNA bases and nucleosides on gold. Journal of the American Chemical Society, 2002, 124, 11248-11249. [0139] 31. B. L. Parsons and M. B. Myers, Personalized cancer treatment and the myth of KRAS wild-type colon tumors. Discovery medicine, 2013, 15, 259-267. [0140] 32. C. Koch, P. C. Li and R. Utkhede, Evaluation of thin films of agarose on glass for hybridization of DNA to identify plant pathogens with microarray technology. Analytical biochemistry, 2005, 342, 93-102. [0141] 33. S. Löfås and A. Mcwhirter, The art of immobilization for SPR sensors. in Surface Plasmon Resonance Based Sensors, Springer, 2006, pp. 117-151. [0142] 34. Saiki, R. K.; Scharf, S.; Faloona, F.; Mullis, K. B.; Horn, G. T.; Erlich, H. A.; Arnheim, N., Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985, 230 (4732), 1350-1354. [0143] 35. Notomi, T.; Okayama, H.; Masubuchi, H.; Yonekawa, T.; Watanabe, K.; Amino, N.; Hase, T., Loop-mediated isothermal amplification of DNA. Nucleic acids research 2000, 28 (12), e63, 1-7. [0144] 36. Lizardi, P. M.; Huang, X.; Zhu, Z.; Bray-Ward, P.; Thomas, D. C.; Ward, D. C., Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nature genetics 1998, 19 (3), 225-232. [0145] 37. Kievits, T.; van Gemen, B.; van Strijp, D.; Schukkink, R.; Dircks, M.; Adriaanse, H.; Malek, L.; Sooknanan, R.; Lens, P., NASBA TM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. Journal of virological methods 1991, 35 (3), 273-286. [0146] 38. Walker, G. T.; Fraiser, M. S.; Schram, J. L.; Little, M. C.; Nadeau, J. G.; Malinowski, D. P., Strand displacement amplification—an isothermal, in vitro DNA amplification technique. Nucleic acids research 1992, 20 (7), 1691-1696. [0147] 39. Vincent, M.; Xu, Y.; Kong, H., Helicase-dependent isothermal DNA amplification. EMBO reports 2004, 5(8), 795-800. [0148] 40. Hicke, B.; Pasko, C.; Groves, B.; Ager, E.; Corpuz, M.; Frech, G.; Munns, D.; Smith, W.; Warcup, A.; Denys, G., Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection. Journal of clinical microbiology 2012, 50 (8), 2681-2687. [0149] 41. Andresen, D.; von Nickisch-Rosenegk, M.; Bier, F. F., Helicase dependent OnChip-amplification and its use in multiplex pathogen detection. Clinica Chimica Acta 2009, 403 (1), 244-248. [0150] 42. Chow, W. H. A.; McCloskey, C.; Tong, Y.; Hu, L.; You, Q.; Kelly, C. P.; Kong, H.; Tang, Y.-W.; Tang, W., Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile. The Journal of Molecular Diagnostics 2008, 10 (5), 452-458. [0151] 43. Gill, P.; Alvandi, A.-H.; Abdul-Tehrani, H.; Sadeghizadeh, M., Colorimetric detection of Helicobacter pylori DNA using isothermal helicase-dependent amplification and gold nanoparticle probes. Diagnostic microbiology and infectious disease 2008, 62 (2), 119-124. [0152] 44. Goldmeyer, J.; Li, H.; McCormac, M.; Cook, S.; Stratton, C.; Lemieux, B.; Kong, H.; Tang, W.; Tang, Y.-W., Identification of Staphylococcus aureus and determination of methicillin resistance directly from positive blood cultures by isothermal amplification and a disposable detection device. Journal of clinical microbiology 2008, 46 (4), 1534-1536. [0153] 45. Kivlehan, F.; Mavré, F.; Talini, L.; Limoges, B.; Marchal, D., Real-time electrochemical monitoring of isothermal helicase-dependent amplification of nucleic acids. Analyst 2011, 136 (18), 3635-3642. [0154] 46. Mahalanabis, M.; Do, J.; ALMuayad, H.; Zhang, J. Y.; Klapperich, C. M., An integrated disposable device for DNA extraction and helicase dependent amplification. Biomedical microdevices 2010, 12 (2), 353-359. [0155] 47. Motré, A.; Li, Y.; Kong, H., Enhancing helicase-dependent amplification by fusing the helicase with the DNA polymerase. Gene 2008, 420 (1), 17-22. [0156] 48. Torres-Chavolla, E.; Alocilja, E. C., Nanoparticle based DNA biosensor for tuberculosis detection using thermophilic helicase-dependent isothermal amplification. Biosensors and Bioelectronics 2011, 26 (11), 4614-4618. [0157] 49. Ramalingam, N.; San, T. C.; Kai, T. J.; Mak, M. Y. M.; Gong, H.-Q., Microfluidic devices harboring unsealed reactors for real-time isothermal helicase-dependent amplification. Microfluidics and nanofluidics 2009, 7 (3), 325-336. [0158] 50. Li, Y.; Jortani, S. A.; Ramey-Hartung, B.; Hudson, E.; Lemieux, B.; Kong, H., Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays. Clinica Chimica Acta 2011, 412 (1), 79-85. [0159] 51. Yuce, M.; Kurt, H.; Mokkapati, V. R.; Budak, H., Employment of nanomaterials in polymerase chain reaction: insight into the impacts and putative operating mechanisms of nano-additives in PCR. RSC Advances 2014, 4 (69), 36800-36814. [0160] 52. Lou, X.; Zhang, Y., Mechanism studies on nanoPCR and applications of gold nanoparticles in genetic analysis. ACS applied materials & interfaces 2013, 5 (13), 6276-6284. [0161] 53. Li, H.; Huang, J.; Lv, J.; An, H.; Zhang, X.; Zhang, Z.; Fan, C.; Hu, J., nanoparticle PCR: Nanogold-Assisted PCR with Enhanced Specifity. Angewandte Chemie International edition 2005, 44(32), 5100-5103. [0162] 54. Li, M.; Lin, Y.-C.; Wu, C.-C.; Liu, H.-S., Enhancing the efficiency of a PCR using gold nanoparticles. Nucleic acids research 2005, 33 (21), e184, 1-10. [0163] 55. Vu, B. V.; Litvinov, D.; Willson, R. C., Gold nanoparticle effects in polymerase chain reaction: favoring of smaller products by polymerase adsorption. Analytical chemistry 2008, 80 (14), 5462-5467. [0164] 56. Mi, L.; Wen, Y.; Pan, D.; Wang, Y.; Fan, C.; Hu, J., Modulation of DNA Polymerase with Gold Nanoparticles and their Applications in Hot-Start PCR. Small 2009, 5(22), 2597-2600. [0165] 57. Tong, Y.; Lemieux, B.; Kong, H., Multiple strategies to improve sensitivity, speed and robustness of isothermal nucleic acid amplification for rapid pathogen detection. BMC biotechnology 2011, 11 (1), 50, 1-7. [0166] 58. Chen, C.; Wang, W.; Ge, J.; Zhao, X. S., Kinetics and thermodynamics of DNA hybridization on gold nanoparticles. Nucleic acids research 2009, 37 (11), 3756-3765. [0167] 59. Cho, K.; Lee, Y.; Lee, C.-H.; Lee, K.; Kim, Y.; Choi, H.; Ryu, P.-D.; Lee, S. Y.; Joo, S.-W., Selective aggregation mechanism of unmodified gold nanoparticles in detection of single nucleotide polymorphism. The Journal of Physical Chemistry C 2008, 112 (23), 8629-8633. [0168] 60. Wan, W.; Yeow, J. T., The effects of gold nanoparticles with different sizes on polymerase chain reaction efficiency. Nanotechnology 2009, 20 (32), 325702, 1-5. [0169] 61. Mandal, S.; Hossain, M.; Muruganandan, T.; Kumar, G. S.; Chaudhuri, K., Gold nanoparticles alter Taq DNA polymerase activity during polymerase chain reaction. RSC Advances 2013, 3 (43), 20793-20799. [0170] 62. An, L.; Tang, W.; Ranalli, T. A.; Kim, H.-J.; Wytiaz, J.; Kong, H., Characterization of a thermostable UvrD helicase and its participation in helicase-dependent amplification. Journal of Biological Chemistry 2005, 280 (32), 28952-28958. [0171] 63. Zhao, W.; Lee, T. M.; Leung, S. S.; Hsing, I.-M., Tunable stabilization of gold nanoparticles in aqueous solutions by mononucleotides. Langmuir 2007, 23 (13), 7143-7147. [0172] 64. Sedighi, A.; Li, P. C., Gold nanoparticle assists SNP detection at room temperature in the nanoBioArray chip. International Journal of Materials Science and Engineering 2013, 1 (1), 45-49. [0173] 65. Wang, L.; Li, P. C., Flexible microarray construction and fast DNA hybridization conducted on a microfluidic chip for greenhouse plant fungal pathogen detection. Journal of agricultural and food chemistry 2007, 55 (26), 10509-10516. [0174] 66. Chim, W.; Li, P. C., Repeated capillary electrophoresis separations conducted on a commercial DNA chip. Analytical Methods 2012, 4 (3), 864-868.
All references cited herein are hereby incorporated by reference. Additionally, U.S. Pat. No. 8,343,778 entitled “microfluidic microarray assemblies and methods of manufacturing and using” and US Patent Application Publication No. US 2012/0108451 entitled “methods and apparatus for nanoparticle-assisted nucleic acid hybridization and microarray analysis” are hereby incorporated by reference.